Zheng‐Li Shi

机构：Yangtze University, Capital Medical University, Chinese Academy of Sciences, Guangzhou Experimental Station, Zhejiang Cancer Hospital, Wuhan Institute of Virology, Research Institute of Petroleum Exploration and Development, Public Health Clinical Center of Chengdu, Beijing Friendship Hospital, University of Chinese Academy of Sciences, Western University of Health Sciences · ORCID：0000-0001-8089-163X

发表论文 324 篇 · 总被引 60023 次 · h-index 57

代表论文

• Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor (2025 · Cell · 被引 97)
• Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses (2025 · Cell · 被引 42)
• Origin and cross-species transmission of bat coronaviruses in China (2024 · Nature Communications · 被引 32)
• Sarbecovirus RBD indels and specific residues dictating multi-species ACE2 adaptiveness (2024 · Nature Communications · 被引 24)
• Design of customized coronavirus receptors (2024 · Nature · 被引 21)
• A Nanoparticle Vaccine Displaying Conserved Epitopes of the Preexisting Neutralizing Antibody Confers Broad Protection against SARS-CoV-2 Variants (2024 · ACS Nano · 被引 20)